News
08-21-2020, 07:03 AM
Hokkaido University scientists have shown that Interleukin-34 is a prognostic marker and drug target for Triple Negative Breast Cancer.
More... (https://www.news-medical.net/news/20200821/Key-molecule-can-be-used-to-assess-prognosis-of-triple-negative-breast-cancer.aspx)
More... (https://www.news-medical.net/news/20200821/Key-molecule-can-be-used-to-assess-prognosis-of-triple-negative-breast-cancer.aspx)